132 related articles for article (PubMed ID: 16844679)
1. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679
[TBL] [Abstract][Full Text] [Related]
2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
4. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
Tapia G; Valenzuela R; Espinosa A; Romanque P; Dossi C; Gonzalez-Mañán D; Videla LA; D'Espessailles A
Mol Nutr Food Res; 2014 Jun; 58(6):1333-41. PubMed ID: 24436018
[TBL] [Abstract][Full Text] [Related]
5. Lipid Emulsion Added to a Liquid High-Carbohydrate Diet and Voluntary Running Exercise Reduce Lipogenesis and Ameliorate Early-Stage Hepatic Steatosis in Mice.
Huang KH; Hao L; Smith PB; Rogers CJ; Patterson AD; Ross AC
J Nutr; 2017 May; 147(5):746-753. PubMed ID: 28298542
[No Abstract] [Full Text] [Related]
6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.
Yang L; Zhang Y; Wang L; Fan F; Zhu L; Li Z; Ruan X; Huang H; Wang Z; Huang Z; Huang Y; Yan X; Chen Y
J Hepatol; 2010 Aug; 53(2):339-47. PubMed ID: 20452699
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in mice.
de Meijer VE; Le HD; Meisel JA; Sharma AK; Popov Y; Puder M
PLoS One; 2011; 6(9):e25587. PubMed ID: 21980496
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Staels B; Rubenstrunk A; Noel B; Rigou G; Delataille P; Millatt LJ; Baron M; Lucas A; Tailleux A; Hum DW; Ratziu V; Cariou B; Hanf R
Hepatology; 2013 Dec; 58(6):1941-52. PubMed ID: 23703580
[TBL] [Abstract][Full Text] [Related]
12. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
de Meijer VE; Sverdlov DY; Popov Y; Le HD; Meisel JA; Nosé V; Schuppan D; Puder M
PLoS One; 2010 Jun; 5(6):e11256. PubMed ID: 20593020
[TBL] [Abstract][Full Text] [Related]
14. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
18. Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease.
Prince E; Lazare FB; Treem WR; Xu J; Iqbal J; Pan X; Josekutty J; Walsh M; Anderson V; Hussain MM; Schwarz SM
JPEN J Parenter Enteral Nutr; 2014 Jul; 38(5):608-16. PubMed ID: 23757305
[TBL] [Abstract][Full Text] [Related]
19. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
20. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ.
Periasamy S; Hsu DZ; Chang PC; Liu MY
J Nutr Biochem; 2014 Mar; 25(3):337-44. PubMed ID: 24445078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
